Synteract Thought Leaders to Address Industry Trends at Upcoming Conferences
RESEARCH TRIANGLE PARK, NC– August 29, 2019 – Synteract, an innovative contract research organization partnering with biotech and pharma companies to bring new medicines to market, will chair, present and exhibit at several key industry conferences this September. Synteract’s leaders will address current therapeutic, regulatory and industry trends and topics impacting clinical development today.
Attendees are invited to come meet with Synteract at any of these upcoming events:
- September 9 – 11: Orphan Drugs and Rare Diseases Global Congress 2019 Americas – Boston, MA – Derek Ansel, Director of Rare and Orphan Diseases at Synteract, will host a roundtable on “Patient-Centric Clinical Development: The importance of patient education for rare disease and advanced therapy trials”
- September 16 – 17: DIA/EFGCP Conference – Better Medicines for Children – Amsterdam – Dr. Martine Dehlinger-Kremer, Vice President, Pediatric Development Europe, will Chair Session 1: “Innovative approaches to pediatric development- State of play and possible impact”
- September 21 – 24: RAPS Regulatory Convergence – Philadelphia, PA –Lynne Marie Georgopoulos, RN, MSHS, RAC, Vice President, Pediatric Development Americas at Synteract, will present “Global Pediatric Drug Development Trivia” on Sept. 23 at 1:00 p.m.
- September 24 – 25: Outsourcing in Clinical Trials Southern California, booth #33 – San Diego, CA – Walter Boyle, Executive Director Biostatistics and Programming at Synteract, will present “Engagement and Analytics – the Simple Path to Value for your Data; or, how ‘Advanced’ do Analytics Really Need to Be?” on Sept. 25 at 10:00 a.m.
Email Kate.Mullis@synteract.com to meet with the Synteract team at any of these upcoming events.
For more information on Synteract’s upcoming conference schedule visit Synteract.com.
